Copyright
©The Author(s) 2022.
World J Gastrointest Pathophysiol. May 22, 2022; 13(3): 85-95
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.85
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.85
Table 1 Biodemographic characteristics and hospitalization trends for 30 d readmissions of Crohn’s disease
| Variable | Year | ||||
| 2010 | 2012 | 2014 | 2016 | 2018 | |
| Number of readmissions | 6202 | 6580 | 6475 | 8278 | 7672 |
| Age (mean ± SE, yr) | 41.8 ± 0.9 | 41.6 ± 1.1 | 41.2 ± 0.8 | 42.5 ± 0.7 | 43.9 ± 0.7 |
| Gender (%) | |||||
| Males | 45.5 | 44.0 | 45.7 | 46.7 | 46.5 |
| Females | 54.5 | 56.0 | 54.3 | 53.3 | 53.5 |
| Charlson comorbidity index score (%) | |||||
| 0 | 69.7 | 72.0 | 69.9 | 64.9 | 61.3 |
| 1 | 19.2 | 15.5 | 17.3 | 19.5 | 20.0 |
| 2 | 5.9 | 6.1 | 6.7 | 7.5 | 9.0 |
| ≥ 3 | 5.2 | 6.4 | 6.1 | 8.1 | 9.7 |
| Insurance type (%) | |||||
| Medicare | 20.5 | 29.1 | 29.3 | 28.9 | 30.6 |
| Medicaid | 21.5 | 24.9 | 26.4 | 25.5 | 24.7 |
| Private | 41.2 | 37.1 | 37.0 | 40.8 | 39.0 |
| Uninsured | 8.8 | 8.9 | 7.3 | 4.8 | 5.7 |
| Household income quartile (%) | |||||
| 1st | 27.8 | 29.2 | 27.9 | 29.0 | 28.6 |
| 2nd | 23.4 | 25.6 | 28.5 | 26.8 | 30.0 |
| 3rd | 24.9 | 25.1 | 22.5 | 24.5 | 23.7 |
| 4th | 23.9 | 20.1 | 21.1 | 19.7 | 17.7 |
| Hospital characteristics | |||||
| Hospital bed size (%) | |||||
| Small | 9.9 | 9.9 | 14.2 | 13.3 | 15.0 |
| Medium | 22.4 | 22.4 | 27.3 | 26.9 | 26.3 |
| Large | 67.7 | 67.7 | 58.5 | 59.8 | 58.7 |
| Teaching status (%) | |||||
| Metropolitan non-teaching | 39.2 | 34.4 | 25.2 | 21.8 | 17.3 |
| Metropolitan teaching | 52.1 | 56.8 | 68.4 | 72.3 | 77.0 |
| Non-metropolitan | 8.7 | 8.8 | 6.4 | 5.9 | 5.7 |
| Hospital volume quintiles (%) | |||||
| Q1 | 1.8 | 1.9 | 1.5 | 1.7 | 1.3 |
| Q2 | 4.3 | 5.4 | 5.1 | 4.2 | 4.5 |
| Q3 | 10.3 | 10.0 | 10.2 | 8.4 | 10.4 |
| Q4 | 19.4 | 18.1 | 18.1 | 18.6 | 19.1 |
| Q5 | 64.2 | 64.6 | 65.1 | 67.1 | 64.7 |
Table 2 Biodemographic characteristics and hospitalization trends for 30 d readmissions of ulcerative colitis
| Variable | Year | ||||
| 2010 | 2012 | 2014 | 2016 | 2018 | |
| Number of readmissions | 3272 | 3399 | 3426 | 4449 | 4234 |
| Age (mean ± SE, yr) | 49.8 ± 1.6 | 49.6 ± 1.5 | 48.4 ± 1.1 | 49.9 ± 1.0 | 51.2 ± 0.8 |
| Gender (%) | |||||
| Males | 48.1 | 45.6 | 47.5 | 46.7 | 49.4 |
| Females | 51.9 | 54.4 | 52.5 | 53.3 | 50.6 |
| Charlson comorbidity index score (%) | |||||
| 0 | 57.8 | 59.6 | 60.6 | 55.6 | 50.9 |
| 1 | 20.3 | 20.0 | 18.6 | 19.4 | 20.7 |
| 2 | 9.4 | 9.0 | 8.5 | 10.6 | 10.3 |
| ≥ 3 | 12.5 | 11.4 | 12.3 | 14.4 | 18.1 |
| Insurance type (%) | |||||
| Medicare | 36.3 | 36.6 | 32.4 | 35.1 | 34.8 |
| Medicaid | 17.8 | 17.0 | 22.3 | 17.5 | 19.5 |
| Private | 39.4 | 37.0 | 40.1 | 42.2 | 40.4 |
| Uninsured | 6.5 | 9.4 | 5.2 | 5.2 | 5.3 |
| Household income quartile (%) | |||||
| 1st | 25.5 | 29.2 | 26.5 | 27.2 | 25.0 |
| 2nd | 22.5 | 23.1 | 25.9 | 27.5 | 26.7 |
| 3rd | 26.4 | 24.6 | 22.9 | 25.0 | 26.1 |
| 4th | 25.6 | 23.1 | 24.7 | 20.3 | 22.2 |
| Hospital characteristics | |||||
| Hospital bed size (%) | |||||
| Small | 10.2 | 9.8 | 13.2 | 13.5 | 16.8 |
| Medium | 19.8 | 22.4 | 26.8 | 25.7 | 24.3 |
| Large | 70.0 | 67.8 | 60.0 | 60.8 | 58.9 |
| Teaching status (%) | |||||
| Metropolitan non-teaching | 37.3 | 38.2 | 26.1 | 24.5 | 19.3 |
| Metropolitan teaching | 53.6 | 53.5 | 67.7 | 70.3 | 76.3 |
| Non-metropolitan | 9.1 | 8.3 | 6.2 | 5.2 | 4.4 |
| Hospital volume quintiles (%) | |||||
| Q1 | 2.4 | 2.4 | 2.5 | 2.1 | 2.0 |
| Q2 | 6.0 | 7.4 | 5.9 | 5.8 | 5.5 |
| Q3 | 11.8 | 10.5 | 11.7 | 10.3 | 12.3 |
| Q4 | 20.2 | 20.1 | 19.0 | 20.4 | 21.4 |
| Q5 | 59.6 | 59.6 | 60.9 | 61.4 | 58.8 |
Table 3 Readmission rates, inpatient mortality, and healthcare burden for 30 d readmissions of Crohn’s disease and ulcerative colitis
| Outcomes | Year | P trend | ||||
| 2010 | 2012 | 2014 | 2016 | 2018 | ||
| Crohn’s disease | ||||||
| All-cause readmission rate (%) | 14.9 | 15.5 | 15.2 | 18.9 | 17.6 | < 0.001 |
| Crohn’s disease specific readmission rate (%) | 7.1 | 6.9 | 7.0 | 8.9 | 8.2 | < 0.001 |
| Crohn’s disease readmission proportion (%) | 54.9 | 51.8 | 53.0 | 55.8 | 54.6 | 0.002 |
| Inpatient mortality (%) | 0.9 | 1.4 | 0.7 | 0.7 | 1.0 | 0.059 |
| Mean length of stay (d) | 5.9 | 5.9 | 5.3 | 6.0 | 6.2 | 0.927 |
| Mean total hospital cost (USD) | 12327 | 13068 | 10988 | 13421 | 14260 | 0.210 |
| Ulcerative colitis | ||||||
| All-cause readmission rate (%) | 14.1 | 14.2 | 13.5 | 16.6 | 15.7 | 0.003 |
| Ulcerative colitis specific readmission rate (%) | 5.2 | 5.3 | 5.2 | 6.1 | 5.6 | 0.029 |
| Ulcerative colitis readmission proportion (%) | 42.6 | 42.4 | 43.4 | 43.0 | 41.0 | 0.566 |
| Inpatient mortality (%) | 2.5 | 1.8 | 2.2 | 2.0 | 2.3 | 0.912 |
| Mean length of stay (d) | 6.8 | 6.8 | 6.3 | 6.8 | 6.9 | 0.452 |
| Mean total hospital cost (USD) | 13783 | 13568 | 13790 | 15358 | 15929 | 0.009 |
- Citation: Dahiya DS, Perisetti A, Kichloo A, Singh A, Goyal H, Rotundo L, Vennikandam M, Shaka H, Singh G, Singh J, Pisipati S, Al-Haddad M, Sanaka MR, Inamdar S. Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma. World J Gastrointest Pathophysiol 2022; 13(3): 85-95
- URL: https://www.wjgnet.com/2150-5330/full/v13/i3/85.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v13.i3.85
